DexCom (DXCM) Releases Preliminary, Unaudited Results for Q4 2025

DexCom, Inc. (NASDAQ:DXCM) is 1 of the Best Fundamental Stocks to Buy According to Analysts. On January 12, the institution released its preliminary, unaudited results for Q4 2025, with full gross coming astatine ~$1.260 billion, reflecting an summation of 13% YoY. Notably, the US gross is projected to beryllium ~$892 million, demonstrating 11% maturation compared to Q4 2024.

DexCom, Inc. (NASDAQ:DXCM) ended 2025 connected a steadfast note, with gross surpassing the high-end of its guidance and the archetypal motorboat of its latest sensor exertion with the G7 15 Day system. Since objective momentum continues to physique passim the CGM category, DexCom, Inc. (NASDAQ:DXCM) is looking guardant to extending its maturation runway done continued innovation arsenic good arsenic grounds procreation successful 2026.

For 2026, DexCom, Inc. (NASDAQ:DXCM) expects full gross of between $5.16 billion – $5.25 billion, exhibiting expected maturation of ~11%-13% implicit 2025. Notably, this outlook takes into information the sensor measurement maturation due to the fact that of expanding CGM consciousness for radical with diabetes, the rollout of Stelo, further planetary expansion, and broader marketplace dynamics.

DexCom, Inc. (NASDAQ:DXCM) is simply a aesculapian instrumentality company, which focuses connected the design, development, and commercialization of continuous glucose monitoring (CGM) systems.

While we admit the imaginable of DXCM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest successful Now

Disclosure: None. This nonfiction is primitively published at Insider Monkey.